NCT03346941已完成不适用
Side Effects After Direct-acting Antiviral Treatment in Patients With Chronic Hepatitis C. The EFINO-C Study.
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 95
- 试验地点
- 1
- 主要终点
- Incidence of side effects
研究概览
简要总结
The objective of this study was to assess the incidence of side effects after direct-acting antiviral therapy in patients with chronic hepatitis C virus infection.
详细描述
Direct-acting antiviral (DAA)-based treatments are today very effective The objective of this study was to assess the incidence of side effects after DAA therapy in patients with chronic hepatitis C virus infection.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •18 years of age or older
- •Hepatitis C virus infection
- •Treatment by direct-acting antiviral combination
排除标准
- •HIV coinfection
结局指标
主要结局
Incidence of side effects
时间窗: Within treatment duration, i.e. 8, 12 or 24 weeks after treatment initiation
Incidence of side effects occurring during treatment duration. Treatment duration may be of 8 weeks, 12 weeks or 24 weeks depending on treatment combination.
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
Unknown
4 期
Effect Of DAAs For Treatment Of HCV On Normal KidneyAntiviral Drug Adverse ReactionNCT03296930Assiut University100
已完成
不适用
Effect of DAAs on Behavior of HCC in HCV PatientsCarcinoma, HepatocellularHepatitis CNCT03200171Al-Azhar University300
已完成
不适用
The effect of generic drugs in treatment of chronic hepatitis C patientsIRCT2017020210417N6Kermanshah University of Medical Sciences60
已完成
不适用
Direct-acting Antiviral Therapy and Reinfection Among PWID With Chronic HCV in Community-based SettingsHepatitis C, ChronicNCT03343925Kirby Institute140
已完成
不适用
Direct-acting Antiviral Therapy and Reinfection Among People With Chronic Hepatitis C Virus Infection and Recent Injecting Drug Use in the Prison SettingHepatitis C, ChronicNCT03740906Kirby Institute202